Association between severity of depression and clinico-biochemical markers of polycystic ovary syndrome
Keywords:
Polycystic ovary syndrome, Depression, Insulin resistance, Testosterone, HirsutismAbstract
Background: Polycystic ovary syndrome (PCOS), as the most common endocrine disorder among reproductive-aged women may lead to psychological morbidity.
Objectives: The present study set out to evaluate the severity of depression in PCOS and non-PCOS women and to evaluate correlation between depression score with body mass index, HOMA-IR, and testosterone level in every group (PCOS and non-PCOS women) in Yazd province.
Methods: In this cross-sectional study, 62 women with PCOS and 61 non- PCOS subjects (20 to 40 years) who were attending Imam-Ali Clinic in Yazd, Iran from September 2014 through March 2015 participated. These persons completed the Beck Depression Short Inventory (BDI-S) Questionnaire. Frequency of depression in PCOD and healthy persons and correlation between depression severity with body mass index, HOMA-IR, testosterone level in PCOS and non- PCOS women were evaluated by ANOVA test and independent-samples t-test and Pearson correlation. P-value of less than 0.05 was considered as statistically significant. Data analyses were performed using SPSS version 16.
Results: Of 62 PCOS subjects, 40 (64.5%) were verified positive for depression, determined by the BDI-S Questionnaire. In the control group, 60.7% had depression. Mean±SE score of depression for PCOS and non-PCOS women were 7.47±5.54 and 7.57±5.77 respectively. There was no statistically significant correlation between body mass index, HOMA-IR, testosterone level with depression score in either group separately or together.
Conclusions: We found considerable amounts of depression in our population. There is no correlation between body mass index, HOMA-IR, and testosterone level with depression score in our study.
References
Kerchner A, Lester W, Stuart SP, Dokras A. Risk of depression and other mental health disorders in
women with polycystic ovary syndrome: a longitudinal study. Fertility and sterility. 2009; 91(1): 207-12.
doi: 10.1016/j.fertnstert.2007.11.022. PMID: 18249398.
Dokras A. Mood and anxiety disorders in women with PCOS. Steroids. 2012; 77(4): 338-41. doi:
1016/j.steroids.2011.12.008. PMID: 22178257.
Rasgon NL, Rao RC, Hwang S, Altshuler LL, Elman S, Zuckerbrow-Miller J, et al. Depression in women
with polycystic ovary syndrome: clinical and biochemical correlates. Journal of affective disorders. 2003;
(3): 299-304. doi: 10.1016/S0165-0327(02)00117-9.
Eshre TR, Group A-SPCW. Revised 2003 consensus on diagnostic criteria and long-term health risks
related to polycystic ovary syndrome. Fertility and sterility. 2004; 81(1): 19-25. doi:
1016/j.fertnstert.2003.10.004.
Deeks AA, Gibson-Helm ME, Teede HJ. Anxiety and depression in polycystic ovary syndrome: a
comprehensive investigation. Fertility and sterility. 2010; 93(7): 2421-3. doi:
1016/j.fertnstert.2009.09.018. PMID: 20117778.
Bhattacharya SM, Jha A. Prevalence and risk of depressive disorders in women with polycystic ovary
syndrome. Fertil Steril. 2010; 94: 357-9. doi: 10.1016/j.fertnstert.2009.09.025. PMID: 19896652.
Coffey S, Bano G, Mason HD. Health-related quality of life in women with polycystic ovary syndrome: a
comparison with the general population using the Polycystic Ovary Syndrome Questionnaire (PCOSQ) and
the Short Form-36 (SF-36). Gynecological endocrinology. 2006; 22(2): 80-6. doi:
1080/09513590600604541. PMID: 16603432.
İrak L, Çinar Yavuz H, Ayçiçek Doğan B, Mete T, Berker D, Güler S. Depression, anxiety, and their
relation with clinical parameters and androgen levels in hirsute women. Turkish Journal of Medical
Sciences. 2016; 46(2): 245-50. doi: 10.3906/sag-1405-72. PMID: 27511480.
Rassi A, Veras AB, dos Reis M, Pastore DL, Bruno LM, Bruno RV, et al. Prevalence of psychiatric
disorders in patients with polycystic ovary syndrome. Comprehensive psychiatry. 2010; 51(6): 599-602.
doi: 10.1016/j.comppsych.2010.02.009. PMID: 20965306.
Weiner CL, Primeau M, Ehrmann DA. Androgens and mood dysfunction in women: comparison of women
with polycystic ovarian syndrome to healthy controls. Psychosom Med. 2004; 66(3): 356-62. PMID:
Bazarganipour F, Ziaei S, Montazeri A, Foroozanfard F, Kazemnejad A, Faghihzadeh S. Psychological
investigation in patients with polycystic ovary syndrome. Health and quality of life outcomes. 2013; 11(1):
Beck AT, Rial WY, Rickels K. Short from of depression inventory: cross validation. Psychological
Reports. 1974; 34: 1184-6. PMID: 4424377.
World Health Organization. Obesity: preventing and managing the global epidemic. World Health
Organization; 2000: 894.
Antuna-Puente B, Disse E, Rabasa-Lhoret R, Laville M, Capeau J, Bastard JP. How can we measure
insulin sensitivity/resistance? Diabetes Metab. 2011; 37: 179-88. doi: 10.1016/j.diabet.2011.01.002. PMID:
Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004; 27: 1487–
doi: 10.2337/diacare.27.6.1487. PMID: 15161807.
Esteghamati A, Ashraf H, Khalilzadeh O, Zandieh A, Nakhjavani M, Rashidi A, et al. Optimal cut-off of
homeostasis model assessment of insulin resistance (HOMA-IR) for the diagnosis of metabolic syndrome:
third national surveillance of risk factors of non-communicable diseases in Iran (SuRFNCD-2007). Nutr
Metab (Lond). 2010; 7: 26. doi: 10.1186/1743-7075-7-26. PMID: 20374655, PMCID: PMC2857836.
Rahiminejad ME, Moaddab A, Rabiee S, Esna-Ashari F, Borzouei S, Hosseini SM. The relationship
between clinicobiochemical markers and depression in women with polycystic ovary syndrome. Iran J
Reprod Med. 2014; 12(12): 811-6. PMID: 25709638, PMCID: PMC4330661.
Sadeghirad B, Haghdoost AA, Amin-Esmaeili M, Shahsavand Ananloo E, Ghaeli G, Rahimi-Movaghar A,
et al. Epidemiology of major depressive disorder in Iran: a systematic review and meta-analysis. Int J Prev
Med. 2010; 1: 81-91. PMID: 21566767, PMCID: PMC3075476.
Barry JA, Kuczmierczyk AR, Hardiman PJ. Anxiety and depression in polycystic ovary syndrome: a
systematic review and meta-analysis. Hum Reprod. 2011; 26: 2442-51. doi: 10.1093/humrep/der197.
PMID: 21725075.
Okamura F, Tashiro A, Utumi A, Imai T, Suchi T, Tamura D, et al. Insulin resistance in patients with
depression and its changes during the clinical course of depression: minimal model analysis. Metabolism
; 49: 1255- 60. doi: 10.1053/meta.2000.9515. PMID: 11079812.
Adriaanse MC, Dekker JM, Nijpels G, Heine RJ, Snoek FJ, Pouwer F. Associations between depressive
symptoms and insulin resistance: the Hoorn Study. Diabetologia. 2006; 49: 2874-7. doi: 10.1007/s00125- 006-0500-4. PMID: 17066302.
Barry JA, Hardiman PJ, Saxby BK, Kuczmierczyk A. Testosterone and mood dysfunction in women with
polycystic ovarian syndrome compared to subfertile controls. J Psychosom Obstet Gynaecol. 2011; 32(2):
-11. doi: 10.3109/0167482X.2011.568129. PMID: 21473679.
Weber B, Lewicka S, Deuschle M, Colla M, Heuser I. Testosterone, androstenedione and
dihydrotestosterone concentrations are elevated in female patients with major depression.
Psychoneuroendocrinology. 2000; 25: 765–71. doi: 10.1016/S0306-4530(00)00023-8.
Douglas GA, Bland MJ. Statistics notes: Absence of evidence is not evidence of absence. BMJ. 1995;
(7003): 485. doi: 10.1136/bmj.311.7003.485.
Published
Issue
Section
License
Copyright (c) 2020 KNOWLEDGE KINGDOM PUBLISHING
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
